iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

sidebar image

Gland Pharma enters agreement to acquire 100% of Cenexi Group

30 Nov 2022 , 09:15 AM

Gland Pharma Limited announced that its wholly-owned subsidiary Gland Pharma International PTE. Ltd, Singapore, has entered into a Put Option Agreement to acquire a 100% stake in Cenexi Group for an equity value not exceeding Euro 120 million (approx. Rs101.36 crore).

Cenexi Group engages in the business of Contract Development & Manufacturing Organisation (CDMO) of pharmaceutical products. It has expertise in sterile liquid and lyophilized fill finished drugs, including capabilities in oncology and complex products.

The company runs four manufacturing sites in Europe, including one site in France and one site in Belgium. It has vast experience in the processing of specific substances like hormones, suspensions, and controlled substances.

Gland Pharma strategically focuses on expanding its CDMO offerings in the European market and building a manufacturing presence. With this acquisition, Gland Pharma will have access to leading know-how and development capabilities in sterile forms including ophthalmic gel, needleless injectors, and hormones.

The proposed acquisition remains subject to receipt of necessary regulatory approvals and satisfaction of certain conditions, said the company in its press release.

At around 9.18 AM, Gland Pharma was trading 2.35% lower at Rs1,833.75 per piece, against previous close of Rs1,877.95 on NSE.

For feedback and suggestions, write to us at editorial@iifl.com

Related Tags

  • Cenexi Group
  • Gland Pharma
  • Gland Pharma Acquisition
  • Gland Pharma news
  • Gland Pharma Share
  • Gland Pharma Stock
  • Gland Pharma Stock Price
sidebar mobile

BLOGS AND PERSONAL FINANCE

Read More

Most Read News

Top Stocks for Today - 25th April 2025
25 Apr 2025|06:47 AM
Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.